Sanofi Antitrust Filing On Regeneron (REGN) Lights Up Rumor Mill
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Regeneron Pharmaceuticals (REGN) resume trading up nearly 7% following Sanofi news
February 11, 2013 10:07 AM ESTRegeneron Pharmaceuticals (NASDAQ: REGN) resume trading up nearly 7% following Sanofi news.... More
Sanofi Antitrust Filing On Regeneron (REGN) Lights Up Rumor Mill
February 11, 2013 10:02 AM ESTThe biotech rumor mill is in overdrive Monday after Regeneron Pharmaceuticals (NASDAQ: REGN) disclosed that it received an antitrust notification from Sanofi (NYSE: SNY) stating that it intends to acquire Common Stock of Regeneron in the open market, or... More
Regeneron Pharmaceuticals (REGN) set to resume trading at 10:05AM after Sanofi News
February 11, 2013 9:47 AM ESTRegeneron Pharmaceuticals (NASDAQ: REGN) will resume trading at 10:05AM ET following news Sanofi (NYSE: SNY) intends to acquire Common Stock of Regeneron through open market purchases and direct purchases from shareholders.... More
Sanofi (SNY) to Acquire Stock of Regeneron (REGN); Will Have $500M+ Stake
February 11, 2013 9:37 AM ESTRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it received from Sanofi a notification under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) that Sanofi (NYSE: SNY) intends to acquire Common Stock of Regeneron through open market purchases... More
Regeneron Pharmaceuticals, Inc. (REGN) trading halted with news pending
February 11, 2013 9:20 AM ESTRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) trading halted with news pending.... More
